JCAHO (Joint Commission on Accreditation of Healthcare Organizations) alerts on jaundice in newborns
This article was originally published in Clinica
The private organisation that accredits US hospitals has issued an alert to providers warning that while jaundice is common and usually not life-threatening in newborns, severe cases put babies at risk for kernicterus, a form of brain damage caused by dangerous levels of bilirubin in the bloodstream.
You may also be interested in...
Lannett will launch a further seven products in fiscal 2021, after launching four products recently in the first quarter of FY21. The company also plans to pay off its Term Loan ‘A’ in full, by the end of November 2020.
Pfizer has now received a formal European Commission approval for its Nyvepria biosimilar pegfilgrastim. The approval puts the firm in direct competition with several other versions of the Neulasta original.
AstraZeneca's research head admits that the half dose approach was a lucky mistake – but one that could boost the vaccine's effectiveness and supplies. The US regulator may not be persuaded, however.